PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia

被引：0
|
作者：
Dalal, Prarthana [1 ]
Dalal, Jignesh [2 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI USA
[2] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Div Hematol Oncol & Bone Marrow Transplant, Cleveland, OH 44106 USA
来源：
LEUKEMIA & LYMPHOMA | 2024年
关键词：
D O I：
10.1080/10428194.2024.2379976
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia
    Hu, Mengze
    Li, Junhui
    Hu, Tao
    Zhang, Zhaoxia
    Feng, Shunqiao
    Xuan, Litian
    Liu, Rong
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [2] Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
    Queralt Salas, Maria
    Atenafu, Eshetu G.
    Datt Law, Arjun
    Lam, Wilson
    Pasic, Ivan
    Chen, Carol
    Kim, Dennis
    Michelis, Fotios, V
    Gerbitz, Armin
    Howard Lipton, Jeffrey
    Mattsson, Jonas
    Kumar, Rajat
    Viswabandya, Auro
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 428.e1 - 428.e9
  • [3] Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis
    Maria Queralt Salas
    Arjun Datt Law
    Wilson Lam
    Zeyad Al-Shaibani
    David Loach
    Dennis Dong Hwan Kim
    Fotios V. Michelis
    Santhosh Thyagu
    Rajat Kumar
    Jeffrey Howard Lipton
    Jonas Mattsson
    Auro Viswabandya
    [J]. Clinical Hematology International, 2019, 1 (2) : 105 - 113
  • [4] Combining Low-Dose Post-Transplant Cyclophosphamide(PTCY) with Anti-Thymocyte Globulin( ATG) for Prophylaxis of Graft-Versus-Host Disease in Alternative-Donor Hematopoietic Stem Cell Transplantation for β-Thalassemia Major
    Lu, Jingyuan
    Zhuang, Yanhong
    Hong, Xiuli
    Chen, Jie
    Chen, Yanxin
    Jiang, Erlie
    Lu, Quanyi
    [J]. BLOOD, 2023, 142
  • [5] Post-transplantation cyclophosphamide compared to graft-versus-host disease prophylaxis with ATG in mismatched unrelated donor hematopoietic stem cell transplantation
    Soltermann, Yves
    Heim, Dominik
    Baldomero, Helen
    Medinger, Michael
    Halter, Jorg P.
    Passweg, Jakob P.
    Kleber, Martina
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 75 - 76
  • [6] Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood
    Xiaoqian Xu
    Jun Yang
    Yu Cai
    Su Li
    Jiahua Niu
    Kun Zhou
    Ying Jiang
    Xiaowei Xu
    Chang Shen
    Chongmei Huang
    Huiying Qiu
    Daolin Wei
    Mei Kang
    Yin Tong
    Zheng Wei
    Peng Liu
    Liping Wan
    Xianmin Song
    [J]. Bone Marrow Transplantation, 2021, 56 : 705 - 708
  • [7] Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood
    Xu, Xiaoqian
    Yang, Jun
    Cai, Yu
    Li, Su
    Niu, Jiahua
    Zhou, Kun
    Jiang, Ying
    Xu, Xiaowei
    Shen, Chang
    Huang, Chongmei
    Qiu, Huiying
    Wei, Daolin
    Kang, Mei
    Tong, Yin
    Wei, Zheng
    Liu, Peng
    Wan, Liping
    Song, Xianmin
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 705 - 708
  • [8] POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) VERSUS ANTI-THYMOCYTE GLOBULIN (ATG) VERSUS COMBINATION FOR GRAFT-VERSUS-HOST DISEASE PREVENTION IN HAPLOIDENTICAL TRANSPLANTATION FOR ADULT ACUTE MYELOID LEUKEMIA: A REPORT FROM THE EBMT
    Bazarbachi, Abdul-Hamid
    Labopin, Myriam
    Angelucci, Emanuele
    Blaise, Didier
    Ciceri, Fabio
    Arcese, William
    Santarone, Stella
    Koc, Yener
    Bramanti, Stefania
    Kulagin, Alexander
    Kwon, Mi
    Sica, Simona
    Sanz, Jaime
    Brissot, Eolia
    Nagler, Arnon
    Mohty, Mohamad
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 64 - 65
  • [9] Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Anti-Thymocyte Globulin As Graft Versus Host Disease Prophylaxis
    Gay, Queralt Salas
    Law, Arjun
    Lam, Wilson
    Al-Shaibani, Zeyad
    Michelis, Fotios V.
    Thyagu, Santhosh
    Kim, Dennis Dong Hwan
    Lipton, Jeff H.
    Kumar, Rajat
    Viswabandya, Auro
    [J]. BLOOD, 2018, 132
  • [10] Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia
    Nagler, Arnon
    Kanate, Abraham S.
    Labopin, Myriam
    Ciceri, Fabio
    Angelucci, Emanuele
    Koc, Yener
    Gulbas, Zafer
    Arcese, William
    Tischer, Johanna
    Pioltelli, Pietro
    Ozdogu, Hakan
    Afanasyev, Boris
    Wu, Depei
    Arat, Mutlu
    Peric, Zinaida
    Giebel, Sebastian
    Savani, Bipin
    Mohty, Mohamad
    [J]. HAEMATOLOGICA, 2021, 106 (06) : 1591 - 1598
12345